Elior SCA (ELIOR)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 1.779 |
|---|---|
| 52-week range | 1.703 – 3.150 |
| Return, 1 month / 3 months | −5.2% / −13.9% |
| Return, 1 year / 3 years | −39.6% / +6.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -41.3% |
| Average daily value traded | 0.76M EUR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Elior is a French contract catering and support services company based in France. It provides food service to businesses, schools, hospitals, care homes and other institutions, running staff restaurants, canteens and catering operations on client premises. The company also offers related services such as cleaning and facility management. Its customers are mainly organisations that outsource their catering and support functions rather than individuals, and it operates across several European countries and beyond.
On this site Elior SCA appears as a stock on the Euronext Paris (France), code ELIOR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Elior SCA (ELIOR) trades on the Euronext Paris in France. It last closed at EUR 1.779 on 19 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 465 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.6% and over the last three months it fell 13.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.4% | ||
| From 52-week high | -40.5% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -13.9% | ||
| 6-month return | -30.7% | ||
| 12-month return, skipping the last month | -36.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.3% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 0.76M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 12 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | −5.2% |
| 3 months | −13.9% |
| 6 months | −30.7% |
| 1 year | −39.6% |
| 3 years | +6.2% |
| 5 years | −70.7% |
Signals
| 50-day / 200-day average | 1.948 / 2.294 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.053 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Feb 2026 | EUR 0.0400 |
| 7 Apr 2020 | EUR 0.2900 |
| 27 Mar 2019 | EUR 0.3400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.